Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Impact of hypertension and diabetes on epidemiology of coronary artery disease

Breadcrumb

  • Home
  • Impact of hypertension and diabetes on epidemiology of coronary artery disease

Ritika Deol 1, * and Vishal Saina 2

1 Clinical research intern Max super specialty, Dehradun. India.
2 Clinical research Coordinator Max super specialty, Ghaziabad., India.

Review Article
 
World Journal of Biology Pharmacy and Health Sciences, 2024, 20(02), 564–578.
Article DOI: 10.30574/wjbphs.2024.20.2.0884
DOI url: https://doi.org/10.30574/wjbphs.2024.20.2.0884

Received on 02 October 2024; revised on 15 November 2024; accepted on 18 November 2024

This study investigates the epidemiological impact of hypertension and diabetes on coronary artery disease (CAD) in a sample of 391 patients from Jodhpur, India. Focusing on the prevalence, duration, and combined effects of these conditions, we assessed their relationships with overall quality of life, treatment satisfaction, and confidence in disease management. The correlation analysis indicated no statistically significant relationships between the duration of hypertension, diabetes, or CAD and quality of life or treatment satisfaction, suggesting these conditions might not independently drive quality-of-life changes within this cohort. Multiple regression analysis highlighted that only age had a significant effect on quality of life (p = 0.025), with older patients reporting slightly higher quality-of-life scores. This model, however, accounted for only 1.9% of the variance in quality of life, underscoring the need for further exploration of other contributing factors. Ordinal logistic regression revealed no significant predictors of confidence in managing conditions, suggesting that unexamined psychosocial or clinical factors may influence patients' self-assessment of disease management capabilities. These findings underscore the multifaceted epidemiological burden of managing comorbid hypertension, diabetes, and CAD, emphasizing the need for integrative public health strategies that address both medical and quality-of-life impacts to enhance patient outcomes in CAD populations.

Epidemiology of Coronary Artery Disease; Hypertension and Diabetes Impact; Quality of Life in CAD Patients; Disease Management Confidence; Chronic Disease Comorbidity

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2024-0884.pdf

Preview Article PDF

Ritika Deol and Vishal Saina. Impact of hypertension and diabetes on epidemiology of coronary artery disease. World Journal of Biology Pharmacy and Health Sciences, 2024, 20(02), 564–578. Article DOI: https://doi.org/10.30574/wjbphs.2024.20.2.0884

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution